MUC4 activates HER2 signalling and enhances the motility of human ovarian cancer cells

Moorthy Palanimuthu Ponnusamy, A. P. Singh, Maneesh Jain, S. Chakraborty, N. Moniaux, Surinder Kumar Batra

Research output: Contribution to journalArticle

52 Citations (Scopus)

Abstract

The mucin MUC4 is a high molecular weight transmembrane glycoprotein. It consists of a mucin-type subunit (MUC4α) and a transmembrane growth factor-like subunit (MUC4β). The mucin MUC4 is overexpressed in many epithelial malignancies including ovarian cancer, suggesting a possible role in the pathogenesis of these cancers. In this study, we investigated the functional role of MUC4 in the human ovarian cancer cell line SKOV3. The mucin MUC4 was ectopically expressed by stable transfection, and its expression was examined by western blot and confocal microscopy analyses. The in vitro studies demonstrated an enhanced motility of MUC4-expressing SKOV3 cells compared with the vector-transfected cells. The mucin MUC4 expression was associated with apparent changes in actin organisation, leading to the formation of microspike, lammelopodia and filopodia-like cellular projections. An enhanced protein expression and activation of HER2, a receptor tyrosine kinase, was also seen, although no significant change was observed in HER-2 transcript levels in the MUC4-transfected SKOV3 cells. Reciprocal co-immunoprecipitation revealed an interaction of MUC4 with HER2. Further, the MUC4-overexpressing SKOV3 cells exhibited an increase in the phosphorylation of focal adhesion kinase (FAK), Akt and ERK, downstream effectors of HER2. Taken together, our findings demonstrate that MUC4 plays a role in ovarian cancer cell motility, in part, by altering actin arrangement and potentiating HER2 downstream signalling in these cells.

Original languageEnglish (US)
Pages (from-to)520-526
Number of pages7
JournalBritish journal of cancer
Volume99
Issue number3
DOIs
StatePublished - Aug 5 2008

Fingerprint

Mucins
Ovarian Neoplasms
Actins
Focal Adhesion Protein-Tyrosine Kinases
Pseudopodia
Receptor Protein-Tyrosine Kinases
Immunoprecipitation
Confocal Microscopy
Cell Movement
Transfection
Neoplasms
Intercellular Signaling Peptides and Proteins
Glycoproteins
Molecular Weight
Western Blotting
Phosphorylation
Cell Line
Proteins

Keywords

  • HER2
  • MUC4
  • Motility
  • Ovarian cancer

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

MUC4 activates HER2 signalling and enhances the motility of human ovarian cancer cells. / Palanimuthu Ponnusamy, Moorthy; Singh, A. P.; Jain, Maneesh; Chakraborty, S.; Moniaux, N.; Batra, Surinder Kumar.

In: British journal of cancer, Vol. 99, No. 3, 05.08.2008, p. 520-526.

Research output: Contribution to journalArticle

@article{d1d8b6fcf1444c989de63cc2dcb1d99a,
title = "MUC4 activates HER2 signalling and enhances the motility of human ovarian cancer cells",
abstract = "The mucin MUC4 is a high molecular weight transmembrane glycoprotein. It consists of a mucin-type subunit (MUC4α) and a transmembrane growth factor-like subunit (MUC4β). The mucin MUC4 is overexpressed in many epithelial malignancies including ovarian cancer, suggesting a possible role in the pathogenesis of these cancers. In this study, we investigated the functional role of MUC4 in the human ovarian cancer cell line SKOV3. The mucin MUC4 was ectopically expressed by stable transfection, and its expression was examined by western blot and confocal microscopy analyses. The in vitro studies demonstrated an enhanced motility of MUC4-expressing SKOV3 cells compared with the vector-transfected cells. The mucin MUC4 expression was associated with apparent changes in actin organisation, leading to the formation of microspike, lammelopodia and filopodia-like cellular projections. An enhanced protein expression and activation of HER2, a receptor tyrosine kinase, was also seen, although no significant change was observed in HER-2 transcript levels in the MUC4-transfected SKOV3 cells. Reciprocal co-immunoprecipitation revealed an interaction of MUC4 with HER2. Further, the MUC4-overexpressing SKOV3 cells exhibited an increase in the phosphorylation of focal adhesion kinase (FAK), Akt and ERK, downstream effectors of HER2. Taken together, our findings demonstrate that MUC4 plays a role in ovarian cancer cell motility, in part, by altering actin arrangement and potentiating HER2 downstream signalling in these cells.",
keywords = "HER2, MUC4, Motility, Ovarian cancer",
author = "{Palanimuthu Ponnusamy}, Moorthy and Singh, {A. P.} and Maneesh Jain and S. Chakraborty and N. Moniaux and Batra, {Surinder Kumar}",
year = "2008",
month = "8",
day = "5",
doi = "10.1038/sj.bjc.6604517",
language = "English (US)",
volume = "99",
pages = "520--526",
journal = "British Journal of Cancer",
issn = "0007-0920",
publisher = "Nature Publishing Group",
number = "3",

}

TY - JOUR

T1 - MUC4 activates HER2 signalling and enhances the motility of human ovarian cancer cells

AU - Palanimuthu Ponnusamy, Moorthy

AU - Singh, A. P.

AU - Jain, Maneesh

AU - Chakraborty, S.

AU - Moniaux, N.

AU - Batra, Surinder Kumar

PY - 2008/8/5

Y1 - 2008/8/5

N2 - The mucin MUC4 is a high molecular weight transmembrane glycoprotein. It consists of a mucin-type subunit (MUC4α) and a transmembrane growth factor-like subunit (MUC4β). The mucin MUC4 is overexpressed in many epithelial malignancies including ovarian cancer, suggesting a possible role in the pathogenesis of these cancers. In this study, we investigated the functional role of MUC4 in the human ovarian cancer cell line SKOV3. The mucin MUC4 was ectopically expressed by stable transfection, and its expression was examined by western blot and confocal microscopy analyses. The in vitro studies demonstrated an enhanced motility of MUC4-expressing SKOV3 cells compared with the vector-transfected cells. The mucin MUC4 expression was associated with apparent changes in actin organisation, leading to the formation of microspike, lammelopodia and filopodia-like cellular projections. An enhanced protein expression and activation of HER2, a receptor tyrosine kinase, was also seen, although no significant change was observed in HER-2 transcript levels in the MUC4-transfected SKOV3 cells. Reciprocal co-immunoprecipitation revealed an interaction of MUC4 with HER2. Further, the MUC4-overexpressing SKOV3 cells exhibited an increase in the phosphorylation of focal adhesion kinase (FAK), Akt and ERK, downstream effectors of HER2. Taken together, our findings demonstrate that MUC4 plays a role in ovarian cancer cell motility, in part, by altering actin arrangement and potentiating HER2 downstream signalling in these cells.

AB - The mucin MUC4 is a high molecular weight transmembrane glycoprotein. It consists of a mucin-type subunit (MUC4α) and a transmembrane growth factor-like subunit (MUC4β). The mucin MUC4 is overexpressed in many epithelial malignancies including ovarian cancer, suggesting a possible role in the pathogenesis of these cancers. In this study, we investigated the functional role of MUC4 in the human ovarian cancer cell line SKOV3. The mucin MUC4 was ectopically expressed by stable transfection, and its expression was examined by western blot and confocal microscopy analyses. The in vitro studies demonstrated an enhanced motility of MUC4-expressing SKOV3 cells compared with the vector-transfected cells. The mucin MUC4 expression was associated with apparent changes in actin organisation, leading to the formation of microspike, lammelopodia and filopodia-like cellular projections. An enhanced protein expression and activation of HER2, a receptor tyrosine kinase, was also seen, although no significant change was observed in HER-2 transcript levels in the MUC4-transfected SKOV3 cells. Reciprocal co-immunoprecipitation revealed an interaction of MUC4 with HER2. Further, the MUC4-overexpressing SKOV3 cells exhibited an increase in the phosphorylation of focal adhesion kinase (FAK), Akt and ERK, downstream effectors of HER2. Taken together, our findings demonstrate that MUC4 plays a role in ovarian cancer cell motility, in part, by altering actin arrangement and potentiating HER2 downstream signalling in these cells.

KW - HER2

KW - MUC4

KW - Motility

KW - Ovarian cancer

UR - http://www.scopus.com/inward/record.url?scp=48349129798&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=48349129798&partnerID=8YFLogxK

U2 - 10.1038/sj.bjc.6604517

DO - 10.1038/sj.bjc.6604517

M3 - Article

C2 - 18665193

AN - SCOPUS:48349129798

VL - 99

SP - 520

EP - 526

JO - British Journal of Cancer

JF - British Journal of Cancer

SN - 0007-0920

IS - 3

ER -